Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 5
2014 2
2015 2
2016 6
2017 5
2018 8
2019 5
2020 4
2021 3
2022 13
2023 8
2024 14
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis.
Siafis S, Çıray O, Wu H, Schneider-Thoma J, Bighelli I, Krause M, Rodolico A, Ceraso A, Deste G, Huhn M, Fraguas D, San José Cáceres A, Mavridis D, Charman T, Murphy DG, Parellada M, Arango C, Leucht S. Siafis S, et al. Among authors: bighelli i. Mol Autism. 2022 Mar 4;13(1):10. doi: 10.1186/s13229-022-00488-4. Mol Autism. 2022. PMID: 35246237 Free PMC article.
Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis.
Schneider-Thoma J, Chalkou K, Dörries C, Bighelli I, Ceraso A, Huhn M, Siafis S, Davis JM, Cipriani A, Furukawa TA, Salanti G, Leucht S. Schneider-Thoma J, et al. Among authors: bighelli i. Lancet. 2022 Feb 26;399(10327):824-836. doi: 10.1016/S0140-6736(21)01997-8. Lancet. 2022. PMID: 35219395 Free article.
Pharmacological treatments in panic disorder in adults: a network meta-analysis.
Guaiana G, Meader N, Barbui C, Davies SJ, Furukawa TA, Imai H, Dias S, Caldwell DM, Koesters M, Tajika A, Bighelli I, Pompoli A, Cipriani A, Dawson S, Robertson L. Guaiana G, et al. Among authors: bighelli i. Cochrane Database Syst Rev. 2023 Nov 28;11(11):CD012729. doi: 10.1002/14651858.CD012729.pub3. Cochrane Database Syst Rev. 2023. PMID: 38014714 Free PMC article.
Family interventions for relapse prevention in schizophrenia: a systematic review and network meta-analysis.
Rodolico A, Bighelli I, Avanzato C, Concerto C, Cutrufelli P, Mineo L, Schneider-Thoma J, Siafis S, Signorelli MS, Wu H, Wang D, Furukawa TA, Pitschel-Walz G, Aguglia E, Leucht S. Rodolico A, et al. Among authors: bighelli i. Lancet Psychiatry. 2022 Mar;9(3):211-221. doi: 10.1016/S2215-0366(21)00437-5. Epub 2022 Jan 31. Lancet Psychiatry. 2022. PMID: 35093198
Efficacy of clozapine versus second-generation antipsychotics in people with treatment-resistant schizophrenia: a systematic review and individual patient data meta-analysis.
Schneider-Thoma J, Hamza T, Chalkou K, Siafis S, Dong S, Bighelli I, Hansen WP, Scheuring E, Davis JM, Priller J, Baumann P, Conley R, Cordes J, Kelly D, Kluge M, Kumra S, Lewis S, Meltzer HY, Naber D, Schooler N, Volavka J, Wahlbeck K, Salanti G, Leucht S. Schneider-Thoma J, et al. Among authors: bighelli i. Lancet Psychiatry. 2025 Apr;12(4):254-265. doi: 10.1016/S2215-0366(25)00001-X. Epub 2025 Feb 26. Lancet Psychiatry. 2025. PMID: 40023172 Free article.
74 results